Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.

Saved in:
Bibliographic Details
Title: Immunogenicity of mRNA vs. BBV152 vaccine boosters against Omicron subvariants: Final results from Phase B of the PRIBIVAC study, a randomized clinical trial.
Authors: Poh XY; National Centre for Infectious Diseases, Singapore., Torres-Ruesta A; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Yoong T; National Centre for Infectious Diseases, Singapore., Wong N; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Tan CW; Duke-NUS Medical School, Singapore., Rouers A; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Chavatte JM; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore., Goh YS; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Rao S; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore., Chia PY; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Ong SWX; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore., Lee TH; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore., Sadarangani SP; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Lin RJH; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore., Neo V; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Kam IKJ; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Huang Y; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Hor PX; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Loh CY; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Yeoh AY; Duke-NUS Medical School, Singapore., Lim DRX; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore., Chia W; Duke-NUS Medical School, Singapore., Ren EC; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Singapore Immunology Network, Agency for Science Technology and Research (A*STAR), Singapore., Lin RTP; National Centre for Infectious Diseases, Singapore; National Public Health Laboratory, Singapore., Fong SW; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore., Renia L; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; School of Biological Sciences, Nanyang Technological University, Singapore., Lye DC; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Wang LF; Duke-NUS Medical School, Singapore., Ng LFP; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK; National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, UK. Electronic address: lisa_ng@IDLabs.a-star.edu.sg., Young BE; National Centre for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore. Electronic address: Barnaby_young@ncid.sg.
Corporate Authors: PRIBIVAC study group; A*STAR Infectious Diseases Labs, Agency for Science Technology and Research (A*STAR), Singapore.
Source: Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126275. Date of Electronic Publication: 2024 Sep 05.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2024.126275